|
Model Number KD-31C-1 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Dyspnea (1816); Hemoptysis (1887); Hemorrhage/Bleeding (1888); Pneumothorax (2012)
|
Event Date 10/21/2022 |
Event Type
Injury
|
Event Description
|
Olympus reviewed the following literature titled "transbronchial needle aspiration combined with cryobiopsy in the diagnosis of mediastinal diseases: a multicentre, open-label, randomised trial.¿ this prospective study aimed to evaluate the efficacy and safety of combined application of endobronchial ultrasound-guided transbronchial needle aspiration (ebus-tbna) and mediastinal cryobiopsy versus ebus-tbna alone for the diagnosis of mediastinal diseases.A total of 271 patients were randomly assigned to receive either ebus-tbna plus transbronchial mediastinal cryobiopsy (combined group; n=136) or ebus-tbna alone (control group; n=135; figure).Sequential application of ebus-tbna and trans bronchial mediastinal cryobiopsy led to a significant increase in the overall diagnostic yield compared with ebus-tbna alone (126 [93%] of 136 participants in the combined group vs 109 [81%] of 135 in the control group.Whereas the combined biopsy was more sensitive than ebus-tbna alone in benign diseases (45 [94%] of 48 vs 28 [64%] of 44, rr 1·47 [95% ci 1·17¿1·86]; p=0·0004.The overall diagnostic yield of 82% (110 of 134 participants) for ebus-tbna and 91% (122 of 134) for cryobiopsy (rr 1·11 [95% ci 1·01¿1·22]; p=0·032).In conclusion, cryobiopsy proved safe and led to a significant gain in overall diagnostic yield compared with ebus-tbna alone.Types of adverse events and number of patients involving the ultrasonic bronchofibervideoscope are as follows: bleeding (grade 3) - 5 patients bleeding (grade 2) - 30 patients coughing - 31 patients dyspnoea - 6 patients haemoptysis - 5 patients pneumothorax - 6 patients pneumomediastinum -1 patient minor bleeding (grade 2) subsided without the need for intervention.The incidence of pneumothorax and pneumomediastinum were detected by chest radiography, although none of these required drainage or other treatment.No serious adverse events were reported during the procedure or at the 4 week follow up.Types of adverse events and number of patients involving the electrosurgical knife are as follows: bleeding (grade 2) - 16 patients bleeding (grade 3) ¿ 3 patients coughing - 19 patients dyspnoea - 2 patients haemoptysis - 3 patients pneumothorax - 6 patients pneumomediastinum -1 patient this literature article requires 2 reports.The related patient identifiers are as follows: (b)(6) / (b)(6)/ (b)(6) this medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
|
|
Manufacturer Narrative
|
The suspect device has not been returned to olympus for evaluation.The literature article is attached for additional information https://doi.Org/10.1016/ s2213-2600(22)00392-7.As the lot number/manufacturing number of the device used is unknown and was not provided, the device history record cannot be investigated.However, olympus conducts inspections and only ships products that pass the inspections.Based on the information available, it is not possible to identify the root cause of the reported event.However, it is likely the reported event is an accident, or a complication associated with a surgical procedure using the subject device.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.The suspect device has not been returned to olympus for evaluation.Olympus will continue to monitor the field performance of this device.
|
|
Search Alerts/Recalls
|
|
|